Regen BioPharma Inc (RGBP) stock
RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
$0.00+0.00 (+50.00%)
Close on Oct 19, 2026Market cap $92.33KP/E –Yield –
Regen BioPharma cash
Cash and short-term investments held at the end of each period.
Regen BioPharma's cash was $239 at Jun 30, 2026. For fiscal 2025 it was $69.56K, up 9614.4% from the year before. Over ten years it grew 6.1% a year on average. The highest annual figure on record is $727.16K in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $69.56K | +9614.4% |
| FY2024 | Sep 30, 2024 | $716 | -99.4% |
| FY2023 | Sep 30, 2023 | $121.04K | +136.4% |
| FY2022 | Sep 30, 2022 | $51.20K | -93.0% |
| FY2021 | Sep 30, 2021 | $727.16K | – |
| FY2020 | Sep 30, 2020 | $0 | -100.0% |
| FY2019 | Sep 30, 2019 | $7.86K | -2.0% |
| FY2018 | Sep 30, 2018 | $8.02K | -97.0% |
| FY2017 | Sep 30, 2017 | $269.97K | +987.6% |
| FY2016 | Sep 30, 2016 | $24.82K | -35.7% |
| FY2015 | Sep 30, 2015 | $38.62K | – |
| FY2014 | Sep 30, 2014 | $0 | -100.0% |
| FY2013 | Sep 30, 2013 | $115.99K | +12466.8% |
| FY2012 | Sep 30, 2012 | $923 | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $239 | -86.4% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $271 | -84.6% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $4.58K | +3291.1% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $69.56K | +9614.4% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $1.76K | -97.2% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $1.76K | -97.7% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $135 | -99.9% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $716 | -99.4% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $61.85K | +8837.7% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $78.12K | -10.9% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $124.50K | +205.6% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $121.04K | +136.4% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $692 | -99.4% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $87.70K | -62.6% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $40.74K | -88.5% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $51.20K | -93.0% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $110.99K | -41.0% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $234.67K | – |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $353.49K | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $727.16K | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $188.18K | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $0 | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $0 | -100.0% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $0 | -100.0% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $0 | -100.0% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $0 | -100.0% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $357 | -99.1% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $7.86K | -2.0% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $1.81K | -96.7% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $15.09K | -51.4% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $39.10K | -85.1% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $8.02K | -97.0% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $55.40K | -86.2% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $31.07K | -72.5% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $261.71K | +18.6% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $269.97K | +987.6% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $401.63K | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $113.16K | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $220.72K | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $24.82K | – |
See a number that looks wrong?